This item requires a subscription to Diabetes Care.
Full Text (PDF)
Original Research - Clinical Care/Education/Nutrition/Psychosocial Research:
Mathijs C. Bunck,
Michaela Diamant,
Anja Cornér,
Bjorn Eliasson,
Jaret L. Malloy,
Rimma M. Shaginian,
Wei Deng,
David M. Kendall,
Marja-Riitta Taskinen,
Ulf Smith,
Hannele Yki-Järvinen,
and Robert J. Heine
One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic
Patients: A randomized, controlled trial Diabetes Care May 2009 32:762-768; published ahead of print February 5, 2009, doi:10.2337/dc08-1797